Your browser doesn't support javascript.
loading
Real-world effectiveness and safety of risankizumab in adult patients with plaque psoriasis: A 1-year international multicenter retrospective cohort study.
Bagit, Ahmed; Maliyar, Khalad; Mansour, Mark; Georgakopoulos, Jorge R; Rankin, Brian; Lytvyn, Yuliya; Zaaroura, Hiba; Park, Ye-Jean; Wang, Emilie; Mufti, Asfandyar; Torres, Tiago; Le, Ana M; Vender, Ronald; Prajapati, Vimal H; Yeung, Jensen.
Afiliação
  • Bagit A; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Maliyar K; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Mansour M; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Rankin B; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Lytvyn Y; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Zaaroura H; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Park YJ; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Wang E; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Mufti A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Torres T; Department of Dermatology, Centro Hospitalar de Santo António, Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
  • Le AM; Department of Dermatology, Centro Hospitalar de Santo António, Porto, Portugal.
  • Vender R; Dermatrials Research Inc. and Venderm Consulting, Hamilton, Ontario, Canada.
  • Prajapati VH; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Dermatology Research Institute, Calgary, Alberta, Canada; Probity Medical Research, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Section of Community Pediatrics
  • Yeung J; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada; Probity Medical Research, Toronto, Onta
J Am Acad Dermatol ; 91(3): 513-515, 2024 Sep.
Article em En | MEDLINE | ID: mdl-38677338
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article